1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease – 2022 report; 2022. Available from: https://goldcopd.org/2022-gold-reports/. Accessed April 15, 2022.
2. Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review
3. World Health Organization. Chronic obstructive pulmonary disease (COPD); 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)). Accessed April 15, 2022.
4. GlaxoSmithKline. Prescribing information for Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder); 2019. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209482s003lbl.pdf. Accessed April 15, 2022.
5. AstraZeneca. Prescribing information for Breztri Aerosphere™ (budesonide, glycopyrrolate, and formoterol fumarate inhalation aerosol); 2020. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212122s000lbl.pdf. Accessed April 15, 2022.